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ADAMs are transmembrane metalloproteases that
control cell behavior by cleaving both cell adhesion
and signaling molecules. The cytoplasmic domain of
ADAMscan regulate theproteolyticactivitybycontrol-
ling the subcellular localization and/or the activationof
the protease domain. Here, we show that the cyto-
plasmic domain of ADAM13 is cleaved and translo-
cates into the nucleus. Preventing this translocation
renders the protein incapable of promoting cranial
neural crest (CNC) cell migration in vivo, without
affecting its proteolytic activity. In addition, the cyto-
plasmic domain of ADAM13 regulates the expression
of multiple genes in CNC, including the protease
Calpain8-a. Restoring the expression of Calpain8-a is
sufficient to rescue CNC migration in the absence of
the ADAM13 cytoplasmic domain. This study shows
that the cytoplasmic domain of ADAM metallopro-
teases can perform essential functions in the nucleus
of cells andmay contribute substantially to the overall
function of the protein.
INTRODUCTION
ADAMs are cell surface metalloproteases that contain a disinte-
grin domain (Alfandari et al., 2009; Blobel, 2005; Wolfsberg et al.,
1995). They are key players in many biological processes and
control cell adhesion and cell signaling. Their role in cell signaling
is linked to their ability to cleave molecules either to turn on
a signal, e.g., by cleaving growth factor precursors (EGF,
TNF-a) or receptors (Notch), or to turn off signals by cleaving
ligand/receptor complexes (e.g., ephrins) (Alfandari et al.,
2009). ADAM proteins have also been shown to regulate cell
adhesion by cleaving N- and E-cadherin to promote epithelial
to mesenchymal transition (EMT). In addition to reducing adhe-
sion of these cells, cleavage of N- and E-cadherins by
ADAM10 releases b-catenin, which translocates into the nucleus
and activates gene transcription, further facilitating EMT (Mar-
etzky et al., 2009; Reiss et al., 2005).
We have previously shown, using both a dominant-negative
(DN) and Morpholino knockdown (KD) approaches, that
ADAM13 plays a critical role in CNC cell migration (Alfandari256 Developmental Cell 20, 256–263, February 15, 2011 ª2011 Elsevet al., 2001; McCusker et al., 2009). In vertebrates, CNC are
responsible for the formation of the face during embryogenesis.
We have previously shown that ADAM13, in collaboration with
other meltrins (ADAM9 and ADAM19), controls CNC cell migra-
tion by cleaving the extracellular domain of Cadherin-11
(McCusker et al., 2009). We have also shown that while its
proteolytic activity is critical for ADAM13 function, the
cytoplasmic domain of the protein is also important for regulating
its function through its interaction with an SH3-containing cyto-
plasmic adaptor protein PACSIN2 (Cousin et al., 2000). In
Xenopus tropicalis, ADAM13 is involved in CNC induction by
cleaving ephrin B ligands and upregulating the canonical Wnt
signaling pathway (Wei et al., 2010).
ADAM cytoplasmic domains are poorly conserved both
between the various ADAMs and also between orthologs in
different species. The ADAM13 cytoplasmic domain, like many
other ADAMs, contains proline-rich (PR) repeats that function
as SH3 binding sites. In addition, the juxta-membrane region
of the cytoplasmic domain is rich in lysine and arginine (KR).
ADAM cytoplasmic domains have been shown to regulate the
ADAM protein functions either through phosphorylation or by
controlling their subcellular localization (Cao et al., 2001a; Ho-
ward et al., 1999; Izumi et al., 1998; Janes et al., 2009; Maretzky
et al., 2009; Stautz et al., 2010; Xu and Derynck, 2010). Recently,
ADAM10 was shown to be cleaved by gamma-secretase,
releasing the cytoplasmic domain from the plasma membrane.
Using inhibitors of nuclear export they were able to detect the
ADAM10 cytoplasmic domain in the nucleus of transfected
293T cells associated with nuclear speckle, which could be
regions of active transcription (Tousseyn et al., 2009).
Here, we show that the ADAM13 cytoplasmic domain is
cleaved in vivo during embryogenesis and translocates into the
nucleus. This translocation is critical for the function of
ADAM13 during CNC cell migration and affects the expression
of multiple genes within these cells. One of these genes
Calpain8-a can rescue CNC migration in embryos lacking the
ADAM13 cytoplasmic domain. We also show that in Xenopus
the cytoplasmic domain of ADAM19 can substitute for the
ADAM13 cytoplasmic domain. Using GFP-fusions of the cyto-
plasmic domains of ADAMs in multiple species we show that
the cytoplasmic domains of Caenorhabditis meltrin (adm-2),
zebrafish ADAM13, and opossum ADAM13 can compensate
for the loss of the Xenopus ADAM13 cytoplasmic domain, while
mouse ADAM33 cannot. These results show that the function of
ADAM cytoplasmic domain in the nucleus has been conserved
during evolution.ier Inc.
Figure 1. ADAM13 and 19 Cooperate during CNC Migration
(A) Schematic representation of the grafts. Donor embryos are injected in one
cell at the 2-cell stage with GFP, or combinations of GFP,MO against ADAM13
and 19 and mRNA encoding various ADAM constructs. At stage 15, CNC are
dissected and grafted into host embryos. CNC migration is visualized using
a fluorescent microscope.
(B) Fluorescence photographs of representative grafted embryos at stage 24.
A positive migration is only counted if cells have progressed ventrally in one or
more of the posterior arches.
(C) Histogram representing the analysis of CNCmigration in at least three inde-
pendent experiments. The error bars correspond to the standard deviation
(SD). n: number of embryos.
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ADAM13 and ADAM19 Cooperate to Promote Cranial
Neural Crest Cell Migration
We have previously shown that three ADAM proteins play a role
during Xenopus CNC migration. ADAM9 and ADAM13 both
cleave Cadherin-11, while ADAM19 does not (McCusker et al.,
2009). We have also shown that ADAM19 is important for the
expression of CNC-specific genes including sox8 and slug (Neu-
ner et al., 2009). To determine whether ADAM13 and 19 could
compensate for each other in CNC migration, we performed
single and double KD using Morpholino oligonucleotides (MO)
that prevent the translation of the endogenous protein
(McCusker et al., 2009; Neuner et al., 2009). CNC cells frommor-
phant embryos were dissected before migration and grafted into
host embryos and the migration of grafted cells was followed
using the green fluorescent protein (GFP) as a lineage tracer (Fig-
ure 1). While single ADAM13 or ADAM19 KD prevents CNC
migration in less than 20%of the embryos, the double KD inhibits
migration in more than 80% of the embryos. CNC migration was
rescued by either ADAM13 or 19 but not the protease inactive
mutants (E/A) or a mutant lacking the cytoplasmic domain
(DCyto), suggesting that both the proteolytic activity and the
cytoplasmic domain are essential.
To determine if the effect on CNCmigration was due to defect
in CNC induction we tested the expression of several CNC
markers in embryos lacking the ADAM13 protein. Our results
show that in the absence of detectable ADAM13 protein, all of
the CNC markers tested (snail2a, snail, slugb, sox8, sox9,
sox10, twist1) were expressed at the right place and the right
level (see Figure S1 available online). These results show that
in Xenopus laevis, ADAM13 KD affects CNC migration in the
absence of any effect on CNC induction.
These results show that ADAM13 and ADAM19 can compen-
sate for each other even though their role in CNC migration
during normal embryo development is distinct. They also show
that the cytoplasmic domain of ADAM13 is essential for CNC
migration. We next investigated how the cytoplasmic domain
of ADAM13 could control cell migration.
The ADAM13 Cytoplasmic Domain Is Cleaved
byGamma-Secretase and Translocates into theNucleus
The ADAM13 extracellular domain is cleaved by autoproteolysis
in the cysteine-rich domain, releasing the active metalloprotease
from the cell surface (Gaultier et al., 2002) (Figure 2A). Ectodo-
main shedding of transmembrane proteins is often followed by
a cleavage by gamma-secretase (GS) that releases the
cytoplasmic domain (Hass et al., 2009). To investigate if a similar
processing occurs for ADAM13, we transfected Cos-7 and 293T
cells with the various ADAM13 constructs. After transfections,
the cytoplasmic and nuclear fractions were separated and
analyzed for the presence of the cytoplasmic fragment using
an antibody directed against this domain (6615F) (Alfandari
et al., 1997). When ADAM13 is transfected into 293T cells,
a 17 kDa fragment is detected in the nuclear extract (Figure 2B,
arrowhead). This is also the case following transfection with
a fusion protein containing the cytoplasmic domain of ADAM13
fused to GFP (GFP-C13) but not with GFP alone. To determine
if the same cleavage also occurs in vivo, we analyzed proteinDevelopmental Cell 20, 256–263, February 15, 2011 ª2011 Elsevier Inc. 257
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MO13. As seen in transfected cells, the ADAM13 antibody
recognizes a 17 kDa fragment present in control embryos but
absent in morphant embryos (Figure 2C). To test if GS is respon-
sible for the cleavage of ADAM13we treated Cos-7 cells with two
pharmacological inhibitors of GS. Indeed, both ILCHO (McLen-
don et al., 2000) and DAPT (Hemming et al., 2008) prevented
the accumulation of the ADAM13 cytoplasmic domain in the
nuclear fractions (Figure 2D). GS are known to cleave proteins
just distal to the transmembrane domain, which for ADAM13
would release a fragment of 21 kDa. Our results showing that
the fragment is approximately of 17 kDa and that the GFP-C13
fusion protein is also cleaved, although never associated with
the plasma membrane, suggest that subsequent cleavage by
a different enzyme may occur following the initial gamma-secre-
tase cleavage. The absence of the 17 kDa fragment in cells
treated with the GS inhibitors suggests that this first step is crit-
ical. Using immunofluorescence, the cytoplasmic domain of
endogenous ADAM13 was also detected in the nucleus of
Xenopus S3 cells in foci that stained less intensely for DAPI sug-
gesting that the DNA in this region is euchromatic and potentially
transcriptionally active (Figure S2).
The nuclear localization depends on the KR subdomain while
the PR subdomain directs a GFP-fusion protein to membrane
ruffles and actin stress fibers (Figure 2E). This is consistent
with a predicted bipartite nuclear localization signal in the KR
region (Hulo et al., 2008), and suggests that, as shown for
ADAM12, the cytoplasmic domain of ADAM13 may interact
with proteins of the cytoskeleton (Cao et al., 2001a). The nuclear
localization of GFP-C13 was also visible when the protein was
expressed in Xenopus embryos (Figure S2C).
To assess the contribution of nuclear localization to the func-
tion of the ADAM13 protein, we introduced a nuclear export
signal (NES), based on the net-NES prediction software
(la Cour et al., 2004), by adding one leucine at position 877 in
the PR domain of both ADAM13 (ADAM13-NES) and GFP-C13.
To test if the NES was functional we expressed GFP-C13NES
in XTC cells and detected its localization in live cells. Depending
on the cell, GFP-C13NES was either entirely cytoplasmic (Fig-
ure 2E) or was present in both the nucleus and the cytoplasm
of XTC cells (data not shown), suggesting that the NES is func-
tional but that it does not prevent the translocation into the
nucleus.
Translocation of the Cytoplasmic Domain Is Critical
for ADAM13 Function during CNC Cell Migration
To investigate the role of the cytoplasmic domain of ADAM13
in vivo, we injected embryos with MO13 alone or together with
MO19. The injections were performed at the 8 to 16-cell stage
in a single cell that contributes to the CNC, and GFP or RFP
was used as a lineage tracer to follow the ability of cells to
migrate in vivo (McCusker et al., 2009) (Figure 3). Injection of
MO13 inhibited CNC migration in 30% of the embryos, while
the coinjection of MO13 and MO19 inhibited migration in 79%
of the embryos. As seen for the grafts, injection of RNA encoding
ADAM13, but notDCyto, rescued CNCmigration. This technique
presents two main advantages over the graft. First, it allows the
injection and analysis of a greater number of embryos enabling
us to test multiple proteins and mutants. Second, since the258 Developmental Cell 20, 256–263, February 15, 2011 ª2011 Elsevembryos do not have to be dissected, the migration pathways
between the epidermis and the mesoderm remain intact, which
could potentially explain why the targeted injection of MO13
inhibits CNC migration more efficiently than in the grafts. For
these reasons, we used the targeted injection for the remainder
of this study.
We then performed complementation experiments by coin-
jecting DCyto together with GFP-C13 in the morphant embryos,
and this combination rescued migration as efficiently as
ADAM13 (Figure 3B). Neither the single point mutant of
ADAM13 containing a NES (A13-NES), nor GFP-C13 alone,
was capable of rescuing migration. While mutations in the cyto-
plasmic domain affected the ability of ADAM13 to promote CNC
migration they did not affect the proteolytic activity, as shown by
the ability to cleave the protocadherin PAPC (Figure 3C). The
abnormal migration in ADAM13 KD was confirmed using in situ
hybridization with twist to detect the position of CNC after migra-
tion (Figure S3).
Taken together, these results show that both the proteolytic
activity and the cytoplasmic domain of ADAM13 are essential
for CNC migration in vivo. They also show that the cytoplasmic
domain does not need to be attached to the extracellular domain
or to the plasma membrane, but only needs to translocate and
remain in the nucleus (absence of rescue by ADAM13-NES) to
perform its critical function.
Since ADAM13 is capable of cleaving itself in the cysteine-rich
domain, we tested whether the autocatalysis of ADAM13 was
essential to generate the cleaved cytoplasmic domain. We in-
jected the E/A-ADAM13, which is incapable of self-processing,
together withDCytomRNA inmorphant embryos. This combina-
tion did not rescue CNC migration (Figure 3E) suggesting that,
in vivo, the initial autocatalytic cleavage is required for the
secondary cleavage by GS.
The ADAM19 Cytoplasmic Domain Can Compensate
for ADAM13
To investigate if other ADAMs could compensate for the loss of
the ADAM13 cytoplasmic domain, we made GFP-fusions with
the cytoplasmic domains of Xenopus ADAM9, 10 and 19 which
all translocated into the nucleus of transfected XTC cells (Fig-
ure 3D). In complementation experiments, the cytoplasmic
domain of ADAM19 was able to rescue migration, while neither
the ADAM9 nor the ADAM10 cytoplasmic domains could (Fig-
ure 3E). Given that ADAM9 can cleave Cadherin-11 (McCusker
et al., 2009) and ADAM19 can compensate for the loss of the
ADAM13 cytoplasmic domain, the presence of both proteins in
the CNC may explain why the loss of ADAM13 only produces
defective migration in 30%–50% of the embryos, while the
double KD of ADAM13 and 19 inhibits migration in 80% of the
embryos.
The Functionality of the ADAM13 Cytoplasmic Domain
Is Evolutionarily Conserved
To test whether the function of the ADAM13 cytoplasmic domain
is evolutionarily conserved, we cloned the cytoplasmic domains
of the putative ADAM13 orthologs from worm (adm-2), zebrafish
(ADAM19a), marsupial (ADAM13), and mouse (ADAM33) in
frame with GFP. While the C. elegans (ceCm), zebrafish
(drC13), and the opossum (mdC13) constructs all translocatedier Inc.
Figure 2. ADAM13Cytoplasmic Domain Translocates to theNucleus
(A) Schematic representation of ADAM13 proteolytic processing (left). The
Pro-domain is cleaved during transit to the cell surface (1). A second extracel-
lular cleavage within the cysteine-rich domain has also been documented (2),
releasing the active protease. The cytoplasmic domain is cleaved by GS (3).
The GFP-fusion protein corresponding to the ADAM13 cytoplasmic domain
and the various mutants are represented (right).
(B) Western blot of ADAM13 cytoplasmic domain. 293T Cells were transfected
with GFP, GFP-C13, and wild-type ADAM13 (A13). Cells were fractionated to
generate a cytoplasmic (C) and a nuclear (N) fraction. Fractions were analyzed
by western blot using a polyclonal antibody to the cytoplasmic domain of
ADAM13 (arrowhead) (Alfandari et al., 1997). All membrane-bound fragments
of ADAM13 are found both in the cytoplasmic fraction (plasma membrane)
and in the nuclear fraction (ER attached to the nuclear membrane). The nuclear
protein PARP is found in the nuclear fraction, while GAPDH is in the cytoplasm.
(C) ADAM13was immunoprecipitated from10 embryos using a goat polyclonal
antibody.Noninjectedembryos (NI) at stage12 (gastrula) and stage18 (neurula)
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Developminto the nucleus and rescued CNC migration, the mouse
(mmC33) construct did neither (Figures 3D and 3E). Using the
mouse constructs, the cytoplasmic domain of ADAM19 but not
ADAM12 was able to rescue CNC migration (Figure 3E). This
demonstrates that even within the meltrin subfamily, the cyto-
plasmic domains, which share proline-rich repeats and basic
residues, possess a relatively strict specificity in regulating cell
migration.Role of the ADAM13 Cytoplasmic Domain
To understand the role of the cytoplasmic domain of ADAM13 in
the nucleus, we then tested if this domain could regulate gene
expression in the CNC. We dissected CNC from embryos in-
jected with either a control MO (CMO), MO13 alone, or with
both MO13 and GFP-C13. Gene expression was assayed using
microarrays on independent triplicate experiments (Affimetrix,
BioMicro Center MIT core facility). The results of the overall anal-
ysis of gene expression show that the variation between exper-
iments is greater than the variation between samples within each
experiment, suggesting that the level of gene expression in
outbred Xenopus populations is highly variable, and that the
analysis should be carried within each batch of sibling embryos
before comparing multiple experiments. These data have been
submitted in NCBI’s Gene Expression Omnibus (Edgar et al.,
2002) and are accessible through GEO series accession number
GSE21517.
We therefore used paired student t test (TM4 software suite
(Saeed et al., 2006)) to identify genes that were significantly
affected by the loss of ADAM13 (p < 0.01). A surprisingly large
number (40%) of genes were identified (matrix2). However within
these 6121 genes, only 172 were increased or decreased by
more than 40%, suggesting that ADAM13 is required for the
correct expression of a large number of genes, and that it serves
to modulate target gene expression rather than switch them on
or off.
We then performed another t test within this first set of genes
(6121) to identify those that were also significantly affected by
the presence of the ADAM13 cytoplasmic domain (p < 0.01),
and found that one third of these genes were (2096, matrix3).
We further consolidated the data by keeping only the genes
that were either reduced or increased with a minimum variation
of 40% (174 genes). Examples of genes affected by the
ADAM13 knockdown and the cytoplasmic domain rescue are
given in Figure 4A. These data show that the ADAM13 cyto-
plasmic domain can modulate the expression of multiple genes
in the CNC cells.Calpain8-a Can Rescue Migration in CNC Lacking
the ADAM13 Cytoplasmic Domain
To identify genes regulated by the ADAM13 cytoplasmic domain
that are essential for CNC migration we performed quantitativeare compared with sibling embryos injected with MO13. The ADAM13 protein
was detected using 6615F.
(D)Cos-7 cells transfectedwithADAM13were treated for 4 hrwithGS inhibitors
(+, ILCHO 50 mM or DAPT 10 mM).
(E) Localization of GFP-fusion proteins expressed in XTC cells. Hoechst was
used to detect the nuclei in cells transfected with GFP-C13NES.
See also Figure S2.
ental Cell 20, 256–263, February 15, 2011 ª2011 Elsevier Inc. 259
Figure 3. ADAM13 Cytoplasmic Domain Is Critical for Cranial Neural Crest Cell Migration
(A) Lateral view of representative embryos injected with RFP and a control MO (CMO) or with MO13 (see also Figure S4). The white arrows point to the fluores-
cence observed in the three main CNC segments (from left to right, Mandibular Hyoid and Branchial).
(B) Histogram representing the percentage of embryos in which CNC migration was inhibited by either MO13 (black bars) or MO13 and MO19 (2MO, gray bars).
The numbers on the right indicate the number of embryos scored for each construct (schematic representation to the left). Statistical significance (at least three
independent experiments) was calculated using a Student’s t test p < 0.05. Significant rescue is indicated with an asterisk (*), and error bars are SD.
(C) Western Blot from Cos-7 cells transfected with various ADAM13 constructs and the protocadherin PAPC. The cell extract (Cell) and the glycoprotein purified
from the culture supernatant (Media) were probed with an antibody to the extracellular domain of PAPC. The cell extract was also probed with the 7C9, a mono-
clonal antibody to the cysteine-rich domain of ADAM13.
(D) Fluorescence images of live XTC cells transfected withGFP-fusion proteins corresponding to the various ADAMcytoplasmic domains. The ADAMnumber and
the species are indicated (xl; Xenopus laevis, dr; Danio rerio, mm; Mus musculus).
(E) Histogram representing the rescue experiments described in (A), using a complementation assay. The total number of embryos scored in at least three inde-
pendent experiments is indicated on the right (N). Asterisk indicate significant rescue (p < 0.05), error bars are SD. The species name is indicated according to
standard nomenclature (ce; Caenorhadbitis elegans, md; Monodelphis domestica).
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or -C19 (Figure 4B). We expected that genes important for
CNC migration would be regulated by GFP-C13 and GFP-C19,
but not GFP-C9 since this construct does not rescue migration
(Figure 3).We found thatCalpain8-a (Capn8-a) was the only gene
tested that fit the hypothesis. To test whether any of these genes
were important for CNC migration, we injected mRNA encoding
each of the candidates together with MO13 and DCyto in
complementation assays. Only Calpain8-a was able to rescue
CNC migration confirming that at least one gene regulated by
the ADAM13 cytoplasmic domain is required for CNC migration
(Figure 4C and 4D). The role of Calpain8-a in CNC migration was
confirmed using both a DN (Cao et al., 2001b) and a KD (MO to260 Developmental Cell 20, 256–263, February 15, 2011 ª2011 Elsevprevent splicing). Using these two reagents in targeted injec-
tions, we found that CNC migration was inhibited by 40%
with the MO and 30% with the DN (Figure 4C). Together these
results demonstrate the importance ofCalpain8-a in CNCmigra-
tion and confirm that one of the essential roles of the ADAM13
cytoplasmic domain is to increase Calpain8-a expression.
DISCUSSION
Role of ADAM Cytoplasmic Domains
The cytoplasmic domains of ADAM10 (Tousseyn et al., 2009)
and ADAM13 are cleaved and translocate into the nucleus, sug-
gesting that this may be a general feature of ADAMs. Our studyier Inc.
Figure 4. The Cytoplasmic Domain of
ADAM13 Regulates Gene Expression
(A) Representative genes were selected from the
microarray data. The average fold change
between the control MO and MO13 (MO13) or
between MO13 and the rescue MO13 plus GFP-
C13 (MO13+C13) is represented as a Log2. Error
bars represent the SD. Four groups of genes are
presented. Xmc (Xenopus Marginal Coil), pafr
(Platelet-activating factor receptor), capn8-a (Cal-
pain8-a), wnt3-A (Wingless-type MMTV integra-
tion site 3A), and pou50 (Pou-homeobox gene
50) are decreased in CNC injected with MO13
and are partially rescued by GFP-C13. nudc
(Nuclear distribution gene C), rad1 (Cell cycle
check point), and vamp8 (Vesicle-associated
membrane protein 8) are increased in CNC lacking
ADAM13, and rescued by GFP-C13. dusp18 (Dual
specificity Phosphatase 18) and mek-2 (Erk
Kinase) are increased in CNC with MO13, while
camK1 (Calcium/calmodulin-dependent protein
kinase 1) and dap (Death-associated protein
kinase 1) are decreased, with no significant effect
from GFP-C13.
(B) Histogram representation of quantitative PCR
data. Amplification was performed from cDNA iso-
lated from CNC of embryos injected with either
MO13 or a combination of MO13, plus the cyto-
plasmic domains of ADAM9 (blue), ADAM13
(red), or ADAM19 (green). Values are represented
as the Log2 fold change compared with MO13
alone. Error bars correspond to the SD between
triplicates. (myt1: myelin transcription factor 1,
fst: follistatin, nubp1: nucleotide binding protein
1, inta6: Integrin alpha 6).
(C) Complementation assays with embryos injected with MO13 plus DCyto alone or with MMP13, Calpain8-a, or Xmc. CNC migration was also measured in
embryos injected with a MO to Calpain8-a or a DN Calpain8-a construct (Capn8-aC105S). The total number of embryos is given (n). Error bars correspond
to the SD. Statistical analysis was done using a Student’s t test. Asterisk represents p values <0.01, for (A) or <0.05 for (B). Representative examples are given
in (D).
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Calpain8-a expression and promote CNC migration. Calpains
have been linked to cell migration but their role is not entirely
solved. They may affect cell migration by cleaving components
of focal adhesions such as integrins, focal adhesion kinase and
talin at the trailing edge of the cell to control the release of the
cell membrane from the substrate (Franco and Huttenlocher,
2005). Other studies have shown that they can cleave b-catenin
to remove the GSK3 phosphorylation sites and generate a stable
form that can translocate into the nucleus and induce the expres-
sion of target genes including those involved in epithelium to
mesenchyme transition (Abe and Takeichi, 2007). The MO that
prevents Calpain8-a splicing will be useful to test the various
hypotheses and determine the exact contribution of this
protease during CNC migration.
Our results clearly show that while multiple ADAMcytoplasmic
domains can translocate into the nucleus, they have distinct and
specific functions that will need to be elucidated for each protein
and may contribute to the overall function of the protein, as well
as the robust effect of the DN constructs that have been used in
the past. These DNs, lacking the proteolytic activity, are often
more potent at producing a phenotype than the elimination of
the protein (Alfandari et al., 2001; Pan and Rubin, 1997). This
could be the result of overexpressing the cytoplasmic domainDevelopmboth in cells that normally express the target ADAM and ectopi-
cally in cells that do not.
In physiological situation, it will be interesting to determine the
role of the cytoplasmic domain of nonproteolytic ADAMs. In
pathological conditions, it will be of interest to define mutations
in the cytoplasmic domain of ADAMs that are associated with
specific diseases and determine if these affect the cleavage,
translocation, or other activity of this domain in and out of the
nucleus.
Evolutionary Conservation of the ADAM13 Protein
Function
Here, we show that the single meltrin found in C. elegans, as well
as the orthologs of ADAM13 in fishes and marsupials but not in
eutherians (placental mammals), can functionally replace the
cytoplasmic domain of Xenopus ADAM13. In eutherians, the
most likely ortholog is ADAM33, but its cytoplasmic domain is
not conserved in either sequence identity (it is acidic rather
than basic) or function. In the mouse and human genomes there
is no better candidate, making it likely that the role of the
ADAM13 cytoplasmic domain has been lost. The duplication of
the single meltrin (c.e.adm-2) during evolution has generated
four distinct ADAMs in vertebrates (ADAM9, 12, 13/33, 19). Of
these, ADAM13 and ADAM19 maintained the original nuclearental Cell 20, 256–263, February 15, 2011 ª2011 Elsevier Inc. 261
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marsupials and eutherians the function was lost in ADAM13/33.
This could have been facilitated by the ability of the ADAM19
cytoplasmic domain to assume ADAM13 role, decreasing the
selection pressure.
It will be interesting to identify the sequence that allows the
ADAM13 and 19 cytoplasmic domains to selectively activate
Calpain8-a and promote CNC migration. Clearly, the proline
repeats and basic amino acids are required but not sufficient
since ADAM9 and 12 possess both but are not capable of
rescuing cell migration.
Conclusions
ADAMs are multifunctional proteins that have been studied
extensively with regard to their proteolytic activities. While this
domain is clearly one of the most important of the protein, the
sum of all domains is required to control not only substrate spec-
ificity and subcellular localization, but also cell signaling.
EXPERIMENTAL PROCEDURES
Morpholinos
Morpholino antisense oligonucleotides (Genetool) against ADAM13 and
ADAM19 have been described previously (McCusker et al., 2009; Neuner
et al., 2009). Two control-morpholinos were used. One corresponds to
a randomly generated sequence of 25mer and the other corresponds to a stan-
dard sequence (CCTCTTACCTCAGTTACAATTTATA). The morpholino anti-
sense oligonucleotide to Calpain8-a (GAAAGTTATGAGACAACACCTGCTT)
was designed to prevent splicing. The realtime PCR primers were used to
amplify genomic DNA containing an intron, which was cloned and sequenced.
The efficiency was tested by realtime PCR from polyA-RNA purified from
embryos injected with 25, 12.5, and 6.25 ng of MO-capn. Eighty percent to
90% KD of calpain8-a mRNA was achieved using the lowest dose. A dose
of 1 ng at the 8-cell stage was chosen for the migration assay.
Antibodies
The following antibodies were used: 6615F: rabbit polyclonal antibody to the
ADAM13 cytoplasmic (Alfandari et al., 1997), gA13: goat polyclonal antibody
to the ADAM13 cytoplasmic, 7C9: mouse monoclonal to the ADAM13
cysteine-rich domain (Gaultier et al., 2002). PARP: mouse monoclonal C2-10
(BD, PharMingen). GAPDH: mouse monoclonal antibody 6C5 (Millipore).
PAPC: mouse monoclonal to the extracellular domain (Chen and Gumbiner,
2006).
Injections
Capped mRNA were synthesized using SP6 RNA polymerase on DNA linear-
ized with NotI as described before (Cousin et al., 2000). For the CNCmigration
assays, embryos were injected at the 16-cell stage in one dorsal animal blas-
tomere with 1 ng of MO, 200 pg of RFP mRNA, and 80 pg of mRNA encoding
various constructs. For the graft assays, embryos were injected at the two cell
stage with 5 ng ofMO, 300 pg of GFPmRNA, 400 pg of ADAM13mRNA, or 200
pg of ADAM19mRNA. Embryoswere raised at 15C until tail bud stage (St. 24–
28) at which time CNCmigration was scored. The percentage of inhibition was
normalized to embryos injected with RFP or GFP alone.
For the gene expression analysis, embryos were injected at the one cell
stage with 10 ng of either a CMO, MO13, or MO13 plus 0.5 ng of GFP-C13.
Embryos were grown at 15C for 48 hr until neurula stage (St. 15–17), at which
point CNC were dissected and immediately placed in a guanidium thioisocya-
nate solution to extract RNA. To control for the viability of the explants, four
CNC explants were placed on fibronectin and imaged by time-lapse micros-
copy using a Zeiss 200M inverted microscope and the openlab4 software (Im-
provision). CNC from each condition were capable of migrating in vitro. RNA
extraction was performed as previously described (Chomczynski and Sacchi,
1987). Total RNA was quantified by absorbance at 260 nm using a nanodrop
(Thermo Scientific).262 Developmental Cell 20, 256–263, February 15, 2011 ª2011 ElsevRNA Amplification/Affymetrix Microarray
RNAwere processed by theMIT core facility as described in the Supplemental
Experimental Methods.
Quantitative PCR
Quantitative PCRwas performed as previously described (Neuner et al., 2009).
All primers were tested for efficiency. Primer sequences are given in Table S4.
cDNA was produced using polyA mRNA purified from 10 CNC explants
(QIAGEN) using direct cDNA kit (Quanta) according to manufacturer’s
instruction.
Cell Culture and Transfection
Cos-7 cells and 293T cells were obtained from ATCC and transfected using
Fugene-6 according to manufacturer’s instruction. Protein analysis was
done 48 hr after transfection. Cos-7 cells were trypsinized while 293T cells
were collected by pipetting into ice cold PBS. Nuclear and cytoplasmic frac-
tions were isolated using the NE-PER kit (Pierce) following manufacturer’s
instruction. For PAPC shedding assay, cells were incubated with media con-
taining 2% serum 24 hr after transfection and conditioned supernatants
were collected at 48 hr. The shed extracellular domain was purified using
Concanavalin-A-agarose (Vector), eluted in reducing Laemmli and blotted
using the PAPC monoclonal antibody (Chen and Gumbiner, 2006).
Fluorescence
Xenopus XTC cells were transfected using Fugene-HD following manufac-
turer’s instruction and placed on FN-coated glass bottom plates (Matek
Corp.). Cells were transfected with the GFP-fusion proteins, and were incu-
bated with Hoechst (Invitrogen) to label nuclei. Photographs were taken using
a Zeiss 200M inverted microscope equipped with an Apotome and a 633
immersion lens to obtain optical sections. For in vivo CNC migration assays,
tailbud stage embryos were imaged using a Nikon fluorescent dissecting
microscope.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found online at doi:10.1016/j.devcel.
2010.12.009.
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